Paper17575148
Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma.
Morgan R and 5 others. Cancer Res, 2007. Cited by 93 papers, by iCite.
Cite this record
ConductScience Library. Antagonism of HOX/PBX dimer formation blocks the in vivo proliferation of melanoma. Papers, record 17575148. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17575148
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Apoptosis | Major topic |
| Homeodomain Proteins | Major topic |
| Melanoma | Major topic |
| Peptides | Major topic |
| Transcription Factors | Major topic |
| Animals | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Genes, Homeobox | |
| Humans | |
| Intercellular Signaling Peptides and Proteins | |
| Mice | |
| Reverse Transcriptase Polymerase Chain Reaction |
Source PubMed
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 93 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42631784 | Homeobox genes in endocrine tumorigenesis: mechanisms, tumor microenvironment interaction, and therapeutic potential. | Med Oncol | 2026 | https://conductscience.org/library/papers/42631784 | PubMed |
| 42339622 | ATRX inactivation disrupts global chromatin state and topology to dysregulate neurodevelopmental pathways in glioma pathogenesis. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/42339622 | PubMed |
| 41495767 | HOXB5 in precision oncology: regulatory networks, functional duality, and clinical prospects. | J Transl Med | 2026 | https://conductscience.org/library/papers/41495767 | PubMed |
| 41350360 | Dysregulation of HOXA genes in acute myeloid leukemia and targeted therapy. | NPJ Precis Oncol | 2025 | https://conductscience.org/library/papers/41350360 | PubMed |
| 41028837 | Defining heterogeneity in core regulatory circuitry reveals HOXB3 condensation as a potential target in glioblastoma. | Nat Cell Biol | 2025 | https://conductscience.org/library/papers/41028837 | PubMed |
| 40725480 | A Subset of HOX Genes Negatively Correlates with HOX/PBX Inhibitor Target Gene Expression and Is Associated with Apoptosis, DNA Repair, and Metabolism in Prostate Cancer. | Genes (Basel) | 2025 | https://conductscience.org/library/papers/40725480 | PubMed |
| 39858044 | The HOX Gene Family's Role as Prognostic and Diagnostic Biomarkers in Hematological and Solid Tumors. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/39858044 | PubMed |
| 39745610 | Using the Conserved Hexapeptide in HOX Proteins as an Antagonist of HOX/PBX Interactions. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/39745610 | PubMed |
| 38192826 | HOXC6: A promising biomarker linked to an immunoevasive microenvironment in colorectal cancer based on TCGA analysis and cohort validation. | Heliyon | 2024 | https://conductscience.org/library/papers/38192826 | PubMed |
| 38062297 | HOXA9 transcription factor is a double-edged sword: from development to cancer progression. | Cancer Metastasis Rev | 2024 | https://conductscience.org/library/papers/38062297 | PubMed |
| 37258584 | Peptides as multifunctional players in cancer therapy. | Exp Mol Med | 2023 | https://conductscience.org/library/papers/37258584 | PubMed |
| 37163604 | Single-cell multiomic analysis identifies a HOX-PBX gene network regulating the survival of lymphangioleiomyomatosis cells. | Sci Adv | 2023 | https://conductscience.org/library/papers/37163604 | PubMed |
| 37163598 | Cell survival pathways targeted in rare lung disease affecting women. | Sci Adv | 2023 | https://conductscience.org/library/papers/37163598 | PubMed |
| 35080776 | Downstream of the HOX genes: Explaining conflicting tumour suppressor and oncogenic functions in cancer. | Int J Cancer | 2022 | https://conductscience.org/library/papers/35080776 | PubMed |
| 34446717 | A TALE/HOX code unlocks WNT signalling response towards paraxial mesoderm. | Nat Commun | 2021 | https://conductscience.org/library/papers/34446717 | PubMed |
| 34330313 | Molecular features and vulnerabilities of recurrent chordomas. | J Exp Clin Cancer Res | 2021 | https://conductscience.org/library/papers/34330313 | PubMed |
| 34073517 | A Computer-Based Methodology to Design Non-Standard Peptides Potentially Able to Prevent HOX-PBX1-Associated Cancer Diseases. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34073517 | PubMed |
| 33375038 | Roles of the HOX Proteins in Cancer Invasion and Metastasis. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/33375038 | PubMed |
| 33214683 | HOX genes promote cell proliferation and are potential therapeutic targets in adrenocortical tumours. | Br J Cancer | 2021 | https://conductscience.org/library/papers/33214683 | PubMed |
| 33033354 | Mapping the native interaction surfaces of PREP1 with PBX1 by cross-linking mass-spectrometry and mutagenesis. | Sci Rep | 2020 | https://conductscience.org/library/papers/33033354 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17575148
GET https://conductscience.org/api/papers/v1/17575148/cited_by?page=2